172 related articles for article (PubMed ID: 34983443)
1. Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study.
Tang H; Liu D; Lu J; He J; Ji S; Liao S; Wei Q; Lu S; Liu Y
BMC Cancer; 2022 Jan; 22(1):33. PubMed ID: 34983443
[TBL] [Abstract][Full Text] [Related]
2. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
[TBL] [Abstract][Full Text] [Related]
3. The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Dan J; Tan J; Huang J; Zhang X; Guo Y; Huang Y; Yang J
Breast Cancer; 2020 Sep; 27(5):982-988. PubMed ID: 32306184
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities.
Chen Z; Zhao G; Chen F; Xia J; Jiang L
BMC Cancer; 2019 Apr; 19(1):329. PubMed ID: 30961549
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.
Jia W; Yuan L; Ni H; Xu B; Zhao P
Technol Cancer Res Treat; 2021; 20():15330338211034291. PubMed ID: 34308689
[TBL] [Abstract][Full Text] [Related]
6. Development of a predictive model utilizing the neutrophil to lymphocyte ratio to predict neoadjuvant chemotherapy efficacy in early breast cancer patients.
Zhu J; Jiao D; Zhao Y; Guo X; Yang Y; Xiao H; Liu Z
Sci Rep; 2021 Jan; 11(1):1350. PubMed ID: 33446717
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients.
Wang H; Huang Z; Xu B; Zhang J; He P; Gao F; Zhang R; Huang X; Shan M
Clin Transl Oncol; 2024 Jun; 26(6):1467-1479. PubMed ID: 38190034
[TBL] [Abstract][Full Text] [Related]
8. Preoperative prognostic nutritional index and systemic immune-inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients.
Ma C; Yu R; Li J; Guo J; Xu J; Wang X; Liu P
J Surg Oncol; 2022 Mar; 125(4):754-765. PubMed ID: 34811745
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of the peripheral platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in predicting pathologic complete response after neoadjuvant chemotherapy in breast cancer patients.
Jin X; Wang K; Shao X; Huang J
Gland Surg; 2022 Jun; 11(6):1057-1066. PubMed ID: 35800742
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a predictor of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: single center experience from Turkey.
Acikgoz O; Yildiz A; Bilici A; Olmez OF; Basim P; Cakir A
Anticancer Drugs; 2022 Nov; 33(10):1150-1155. PubMed ID: 36206103
[TBL] [Abstract][Full Text] [Related]
11. A new model of preoperative systemic inflammatory markers predicting overall survival of osteosarcoma: a multicenter retrospective study.
Huang X; Liu Y; Liang W; Luo K; Qin Y; Li F; Xie T; Qin H; He J; Wei Q
BMC Cancer; 2022 Dec; 22(1):1370. PubMed ID: 36585638
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil to lymphocyte ratio is a prognostic factor for disease free survival in patients with breast cancer underwent curative resection.
Geng SK; Fu SM; Fu YP; Zhang HW
Medicine (Baltimore); 2018 Aug; 97(35):e11898. PubMed ID: 30170382
[TBL] [Abstract][Full Text] [Related]
14. Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients.
Eren T; Karacin C; Ucar G; Ergun Y; Yazici O; İmamoglu Gİ; Ozdemir N
Medicine (Baltimore); 2020 May; 99(22):e20346. PubMed ID: 32481414
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience.
Bastard P; Cozic N; Brion R; Gaspar N; Piperno-Neumann S; Cordero C; Leculée-Thébaud E; Gomez-Mascard A; Rédini F; Marchais A; Ikonomova R; Cleirec M; Laurence V; Rigaud C; Abbas R; Verrecchia F; Brugières L; Minard-Colin V
Pediatr Blood Cancer; 2024 Jul; 71(7):e31029. PubMed ID: 38679845
[TBL] [Abstract][Full Text] [Related]
16. Texture analysis for chemotherapy response evaluation in osteosarcoma using MR imaging.
Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
NMR Biomed; 2021 Feb; 34(2):e4426. PubMed ID: 33078438
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
Chen Y; Chen K; Xiao X; Nie Y; Qu S; Gong C; Su F; Song E
BMC Cancer; 2016 May; 16():320. PubMed ID: 27198767
[TBL] [Abstract][Full Text] [Related]
18. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
[No Abstract] [Full Text] [Related]
19. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
